United Laboratories (03933): Marketing registration application for semaglutide injection accepted

Zhitong Finance APP News, United Laboratories International Holdings Limited (03933) announced that the weight management indication marketing registration application for semaglutide injection submitted by the company's wholly-owned subsidiary Zhuhai United Laboratories Biopharmaceutical Co., Ltd. has been accepted by China's National Medical Products Administration. The acceptance numbers are CXSS2600179, CXSS2600180, CXSS2600181, CXSS2600182, and CXSS2600183.